Interdisciplinary consensus on indications for transfemoral transcatheter aortic valve implantation (TF-TAVI)

Indications for TF-TAVI (transfemoral transcatheter aortic valve implantation) are rapidly changing according to increasing evidence from randomized controlled trials. Present trials document the non-inferiority or even superiority of TF-TAVI in intermediate-risk patients (STS-Score 4–8%) as well as...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical research in cardiology 2020-01, Vol.109 (1), p.1-12
Hauptverfasser: von Scheidt Wolfgang, Welz, A, Pauschinger, M, Fischlein, T, Schächinger, V, Treede, H, Zahn, R, Hennersdorf, M, Albes, J M, Bekeredjian, R, Beyer, M, Brachmann, J, Butter, C, Bruch, L, Dörge, H, Eichinger, W, Franke U F W, Friedel, N, Giesler, T, Gradaus, R, Hambrecht, R, Haude, M, Hausmann, H, Heintzen, M P, Jung, W, Kerber, S, Mudra, H, Nordt, T, Pizzulli, L, F-U, Sack, Sack, S, Schumacher, B, Schymik, G, Sechtem, U, Stellbrink, C, Stumpf, C, Hoffmeister, H M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 12
container_issue 1
container_start_page 1
container_title Clinical research in cardiology
container_volume 109
creator von Scheidt Wolfgang
Welz, A
Pauschinger, M
Fischlein, T
Schächinger, V
Treede, H
Zahn, R
Hennersdorf, M
Albes, J M
Bekeredjian, R
Beyer, M
Brachmann, J
Butter, C
Bruch, L
Dörge, H
Eichinger, W
Franke U F W
Friedel, N
Giesler, T
Gradaus, R
Hambrecht, R
Haude, M
Hausmann, H
Heintzen, M P
Jung, W
Kerber, S
Mudra, H
Nordt, T
Pizzulli, L
F-U, Sack
Sack, S
Schumacher, B
Schymik, G
Sechtem, U
Stellbrink, C
Stumpf, C
Hoffmeister, H M
description Indications for TF-TAVI (transfemoral transcatheter aortic valve implantation) are rapidly changing according to increasing evidence from randomized controlled trials. Present trials document the non-inferiority or even superiority of TF-TAVI in intermediate-risk patients (STS-Score 4–8%) as well as in low-risk patients (STS-Score 
doi_str_mv 10.1007/s00392-019-01528-5
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_2272481715</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2272481715</sourcerecordid><originalsourceid>FETCH-LOGICAL-c775-2a0768b5db35618f2dd120cf27b11224d3758867bc0d11d19d0e1fcc125ba5f53</originalsourceid><addsrcrecordid>eNo9TctKAzEUDaJgrf6Aq4AbXUTvzUwmmWURq4WCm8FtyeSBKdOkJtOCf-9gxcXlvDjnEnKL8IgA8qkAVC1ngO10gismzsgMVYMMmpaf_3NVX5KrUrYAAqGqZ2S3iqPLNhQT9kOIOn9Tk2JxsRwKTZGGaIPRY5g86lOmY9axeLdLWQ8nMaWfbtqgOuUxGHrUw9HRsNsPOo6_TXrfLVm3-Fg9XJMLr4fibv5wTrrlS_f8xtbvr6vnxZoZKQXjGmSjemH7SjSoPLcWORjPZY_IeW0rKZRqZG_AIlpsLTj0xiAXvRZeVHNyd5rd5_R1cGXcbNMhx-njhnPJa4USRfUD635cXQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2272481715</pqid></control><display><type>article</type><title>Interdisciplinary consensus on indications for transfemoral transcatheter aortic valve implantation (TF-TAVI)</title><source>Springer Nature - Complete Springer Journals</source><creator>von Scheidt Wolfgang ; Welz, A ; Pauschinger, M ; Fischlein, T ; Schächinger, V ; Treede, H ; Zahn, R ; Hennersdorf, M ; Albes, J M ; Bekeredjian, R ; Beyer, M ; Brachmann, J ; Butter, C ; Bruch, L ; Dörge, H ; Eichinger, W ; Franke U F W ; Friedel, N ; Giesler, T ; Gradaus, R ; Hambrecht, R ; Haude, M ; Hausmann, H ; Heintzen, M P ; Jung, W ; Kerber, S ; Mudra, H ; Nordt, T ; Pizzulli, L ; F-U, Sack ; Sack, S ; Schumacher, B ; Schymik, G ; Sechtem, U ; Stellbrink, C ; Stumpf, C ; Hoffmeister, H M</creator><creatorcontrib>von Scheidt Wolfgang ; Welz, A ; Pauschinger, M ; Fischlein, T ; Schächinger, V ; Treede, H ; Zahn, R ; Hennersdorf, M ; Albes, J M ; Bekeredjian, R ; Beyer, M ; Brachmann, J ; Butter, C ; Bruch, L ; Dörge, H ; Eichinger, W ; Franke U F W ; Friedel, N ; Giesler, T ; Gradaus, R ; Hambrecht, R ; Haude, M ; Hausmann, H ; Heintzen, M P ; Jung, W ; Kerber, S ; Mudra, H ; Nordt, T ; Pizzulli, L ; F-U, Sack ; Sack, S ; Schumacher, B ; Schymik, G ; Sechtem, U ; Stellbrink, C ; Stumpf, C ; Hoffmeister, H M</creatorcontrib><description>Indications for TF-TAVI (transfemoral transcatheter aortic valve implantation) are rapidly changing according to increasing evidence from randomized controlled trials. Present trials document the non-inferiority or even superiority of TF-TAVI in intermediate-risk patients (STS-Score 4–8%) as well as in low-risk patients (STS-Score &lt; 4%). However, risk scores exhibit limitations and, as a single criterion, are unable to establish an appropriate indication of TF-TAVI vs transapical TAVI vs SAVR (surgical aortic valve replacement). The ESC (European Society of Cardiology)/EACTS (European Association for Cardio-Thoracic Surgery) guidelines 2017 and the German DGK (Deutsche Gesellschaft für Kardiologie)/DGTHG (Deutsche Gesellschaft für Thorax-, Herz- und Gefäßchirurgie) commentary 2018 offer a framework for the selection of the best therapeutic method, but the individual decision is left to the discretion of the heart teams. An interdisciplinary TAVI consensus group of interventional cardiologists of the ALKK (Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte e.V.) and cardiac surgeons has developed a detailed consensus on the indications for TF-TAVI to provide an up-to-date, evidence-based, comprehensive decision matrix for daily practice. The matrix of indication criteria includes age, risk scores, contraindications against SAVR (e.g., porcelain aorta), cardiovascular criteria pro TAVI, additional criteria pro TAVI (e.g., frailty, comorbidities, organ dysfunction), contraindications against TAVI (e.g., endocarditis) and cardiovascular criteria pro SAVR (e.g., bicuspid valve anatomy). This interdisciplinary consensus may provide orientation to heart teams for individual TAVI-indication decisions. Future adaptations according to evolving medical evidence are to be expected.Graphic abstractInterdisciplinary consensus on indications for transfemoral transcatheter aortic valve implantation (TF-TAVI).</description><identifier>ISSN: 1861-0684</identifier><identifier>EISSN: 1861-0692</identifier><identifier>DOI: 10.1007/s00392-019-01528-5</identifier><language>eng</language><publisher>Heidelberg: Springer Nature B.V</publisher><subject>Adaptation ; Aorta ; Aortic valve ; Cardiology ; Clinical trials ; Criteria ; Endocarditis ; Heart ; Implantation ; Indication ; Interdisciplinary aspects ; Medical personnel ; Patients ; Porcelain ; Risk ; Surgeons ; Surgery ; Thoracic surgery ; Thorax</subject><ispartof>Clinical research in cardiology, 2020-01, Vol.109 (1), p.1-12</ispartof><rights>Clinical Research in Cardiology is a copyright of Springer, (2019). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c775-2a0768b5db35618f2dd120cf27b11224d3758867bc0d11d19d0e1fcc125ba5f53</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>von Scheidt Wolfgang</creatorcontrib><creatorcontrib>Welz, A</creatorcontrib><creatorcontrib>Pauschinger, M</creatorcontrib><creatorcontrib>Fischlein, T</creatorcontrib><creatorcontrib>Schächinger, V</creatorcontrib><creatorcontrib>Treede, H</creatorcontrib><creatorcontrib>Zahn, R</creatorcontrib><creatorcontrib>Hennersdorf, M</creatorcontrib><creatorcontrib>Albes, J M</creatorcontrib><creatorcontrib>Bekeredjian, R</creatorcontrib><creatorcontrib>Beyer, M</creatorcontrib><creatorcontrib>Brachmann, J</creatorcontrib><creatorcontrib>Butter, C</creatorcontrib><creatorcontrib>Bruch, L</creatorcontrib><creatorcontrib>Dörge, H</creatorcontrib><creatorcontrib>Eichinger, W</creatorcontrib><creatorcontrib>Franke U F W</creatorcontrib><creatorcontrib>Friedel, N</creatorcontrib><creatorcontrib>Giesler, T</creatorcontrib><creatorcontrib>Gradaus, R</creatorcontrib><creatorcontrib>Hambrecht, R</creatorcontrib><creatorcontrib>Haude, M</creatorcontrib><creatorcontrib>Hausmann, H</creatorcontrib><creatorcontrib>Heintzen, M P</creatorcontrib><creatorcontrib>Jung, W</creatorcontrib><creatorcontrib>Kerber, S</creatorcontrib><creatorcontrib>Mudra, H</creatorcontrib><creatorcontrib>Nordt, T</creatorcontrib><creatorcontrib>Pizzulli, L</creatorcontrib><creatorcontrib>F-U, Sack</creatorcontrib><creatorcontrib>Sack, S</creatorcontrib><creatorcontrib>Schumacher, B</creatorcontrib><creatorcontrib>Schymik, G</creatorcontrib><creatorcontrib>Sechtem, U</creatorcontrib><creatorcontrib>Stellbrink, C</creatorcontrib><creatorcontrib>Stumpf, C</creatorcontrib><creatorcontrib>Hoffmeister, H M</creatorcontrib><title>Interdisciplinary consensus on indications for transfemoral transcatheter aortic valve implantation (TF-TAVI)</title><title>Clinical research in cardiology</title><description>Indications for TF-TAVI (transfemoral transcatheter aortic valve implantation) are rapidly changing according to increasing evidence from randomized controlled trials. Present trials document the non-inferiority or even superiority of TF-TAVI in intermediate-risk patients (STS-Score 4–8%) as well as in low-risk patients (STS-Score &lt; 4%). However, risk scores exhibit limitations and, as a single criterion, are unable to establish an appropriate indication of TF-TAVI vs transapical TAVI vs SAVR (surgical aortic valve replacement). The ESC (European Society of Cardiology)/EACTS (European Association for Cardio-Thoracic Surgery) guidelines 2017 and the German DGK (Deutsche Gesellschaft für Kardiologie)/DGTHG (Deutsche Gesellschaft für Thorax-, Herz- und Gefäßchirurgie) commentary 2018 offer a framework for the selection of the best therapeutic method, but the individual decision is left to the discretion of the heart teams. An interdisciplinary TAVI consensus group of interventional cardiologists of the ALKK (Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte e.V.) and cardiac surgeons has developed a detailed consensus on the indications for TF-TAVI to provide an up-to-date, evidence-based, comprehensive decision matrix for daily practice. The matrix of indication criteria includes age, risk scores, contraindications against SAVR (e.g., porcelain aorta), cardiovascular criteria pro TAVI, additional criteria pro TAVI (e.g., frailty, comorbidities, organ dysfunction), contraindications against TAVI (e.g., endocarditis) and cardiovascular criteria pro SAVR (e.g., bicuspid valve anatomy). This interdisciplinary consensus may provide orientation to heart teams for individual TAVI-indication decisions. Future adaptations according to evolving medical evidence are to be expected.Graphic abstractInterdisciplinary consensus on indications for transfemoral transcatheter aortic valve implantation (TF-TAVI).</description><subject>Adaptation</subject><subject>Aorta</subject><subject>Aortic valve</subject><subject>Cardiology</subject><subject>Clinical trials</subject><subject>Criteria</subject><subject>Endocarditis</subject><subject>Heart</subject><subject>Implantation</subject><subject>Indication</subject><subject>Interdisciplinary aspects</subject><subject>Medical personnel</subject><subject>Patients</subject><subject>Porcelain</subject><subject>Risk</subject><subject>Surgeons</subject><subject>Surgery</subject><subject>Thoracic surgery</subject><subject>Thorax</subject><issn>1861-0684</issn><issn>1861-0692</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNo9TctKAzEUDaJgrf6Aq4AbXUTvzUwmmWURq4WCm8FtyeSBKdOkJtOCf-9gxcXlvDjnEnKL8IgA8qkAVC1ngO10gismzsgMVYMMmpaf_3NVX5KrUrYAAqGqZ2S3iqPLNhQT9kOIOn9Tk2JxsRwKTZGGaIPRY5g86lOmY9axeLdLWQ8nMaWfbtqgOuUxGHrUw9HRsNsPOo6_TXrfLVm3-Fg9XJMLr4fibv5wTrrlS_f8xtbvr6vnxZoZKQXjGmSjemH7SjSoPLcWORjPZY_IeW0rKZRqZG_AIlpsLTj0xiAXvRZeVHNyd5rd5_R1cGXcbNMhx-njhnPJa4USRfUD635cXQ</recordid><startdate>20200101</startdate><enddate>20200101</enddate><creator>von Scheidt Wolfgang</creator><creator>Welz, A</creator><creator>Pauschinger, M</creator><creator>Fischlein, T</creator><creator>Schächinger, V</creator><creator>Treede, H</creator><creator>Zahn, R</creator><creator>Hennersdorf, M</creator><creator>Albes, J M</creator><creator>Bekeredjian, R</creator><creator>Beyer, M</creator><creator>Brachmann, J</creator><creator>Butter, C</creator><creator>Bruch, L</creator><creator>Dörge, H</creator><creator>Eichinger, W</creator><creator>Franke U F W</creator><creator>Friedel, N</creator><creator>Giesler, T</creator><creator>Gradaus, R</creator><creator>Hambrecht, R</creator><creator>Haude, M</creator><creator>Hausmann, H</creator><creator>Heintzen, M P</creator><creator>Jung, W</creator><creator>Kerber, S</creator><creator>Mudra, H</creator><creator>Nordt, T</creator><creator>Pizzulli, L</creator><creator>F-U, Sack</creator><creator>Sack, S</creator><creator>Schumacher, B</creator><creator>Schymik, G</creator><creator>Sechtem, U</creator><creator>Stellbrink, C</creator><creator>Stumpf, C</creator><creator>Hoffmeister, H M</creator><general>Springer Nature B.V</general><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M7Z</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20200101</creationdate><title>Interdisciplinary consensus on indications for transfemoral transcatheter aortic valve implantation (TF-TAVI)</title><author>von Scheidt Wolfgang ; Welz, A ; Pauschinger, M ; Fischlein, T ; Schächinger, V ; Treede, H ; Zahn, R ; Hennersdorf, M ; Albes, J M ; Bekeredjian, R ; Beyer, M ; Brachmann, J ; Butter, C ; Bruch, L ; Dörge, H ; Eichinger, W ; Franke U F W ; Friedel, N ; Giesler, T ; Gradaus, R ; Hambrecht, R ; Haude, M ; Hausmann, H ; Heintzen, M P ; Jung, W ; Kerber, S ; Mudra, H ; Nordt, T ; Pizzulli, L ; F-U, Sack ; Sack, S ; Schumacher, B ; Schymik, G ; Sechtem, U ; Stellbrink, C ; Stumpf, C ; Hoffmeister, H M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c775-2a0768b5db35618f2dd120cf27b11224d3758867bc0d11d19d0e1fcc125ba5f53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adaptation</topic><topic>Aorta</topic><topic>Aortic valve</topic><topic>Cardiology</topic><topic>Clinical trials</topic><topic>Criteria</topic><topic>Endocarditis</topic><topic>Heart</topic><topic>Implantation</topic><topic>Indication</topic><topic>Interdisciplinary aspects</topic><topic>Medical personnel</topic><topic>Patients</topic><topic>Porcelain</topic><topic>Risk</topic><topic>Surgeons</topic><topic>Surgery</topic><topic>Thoracic surgery</topic><topic>Thorax</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>von Scheidt Wolfgang</creatorcontrib><creatorcontrib>Welz, A</creatorcontrib><creatorcontrib>Pauschinger, M</creatorcontrib><creatorcontrib>Fischlein, T</creatorcontrib><creatorcontrib>Schächinger, V</creatorcontrib><creatorcontrib>Treede, H</creatorcontrib><creatorcontrib>Zahn, R</creatorcontrib><creatorcontrib>Hennersdorf, M</creatorcontrib><creatorcontrib>Albes, J M</creatorcontrib><creatorcontrib>Bekeredjian, R</creatorcontrib><creatorcontrib>Beyer, M</creatorcontrib><creatorcontrib>Brachmann, J</creatorcontrib><creatorcontrib>Butter, C</creatorcontrib><creatorcontrib>Bruch, L</creatorcontrib><creatorcontrib>Dörge, H</creatorcontrib><creatorcontrib>Eichinger, W</creatorcontrib><creatorcontrib>Franke U F W</creatorcontrib><creatorcontrib>Friedel, N</creatorcontrib><creatorcontrib>Giesler, T</creatorcontrib><creatorcontrib>Gradaus, R</creatorcontrib><creatorcontrib>Hambrecht, R</creatorcontrib><creatorcontrib>Haude, M</creatorcontrib><creatorcontrib>Hausmann, H</creatorcontrib><creatorcontrib>Heintzen, M P</creatorcontrib><creatorcontrib>Jung, W</creatorcontrib><creatorcontrib>Kerber, S</creatorcontrib><creatorcontrib>Mudra, H</creatorcontrib><creatorcontrib>Nordt, T</creatorcontrib><creatorcontrib>Pizzulli, L</creatorcontrib><creatorcontrib>F-U, Sack</creatorcontrib><creatorcontrib>Sack, S</creatorcontrib><creatorcontrib>Schumacher, B</creatorcontrib><creatorcontrib>Schymik, G</creatorcontrib><creatorcontrib>Sechtem, U</creatorcontrib><creatorcontrib>Stellbrink, C</creatorcontrib><creatorcontrib>Stumpf, C</creatorcontrib><creatorcontrib>Hoffmeister, H M</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biochemistry Abstracts 1</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Clinical research in cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>von Scheidt Wolfgang</au><au>Welz, A</au><au>Pauschinger, M</au><au>Fischlein, T</au><au>Schächinger, V</au><au>Treede, H</au><au>Zahn, R</au><au>Hennersdorf, M</au><au>Albes, J M</au><au>Bekeredjian, R</au><au>Beyer, M</au><au>Brachmann, J</au><au>Butter, C</au><au>Bruch, L</au><au>Dörge, H</au><au>Eichinger, W</au><au>Franke U F W</au><au>Friedel, N</au><au>Giesler, T</au><au>Gradaus, R</au><au>Hambrecht, R</au><au>Haude, M</au><au>Hausmann, H</au><au>Heintzen, M P</au><au>Jung, W</au><au>Kerber, S</au><au>Mudra, H</au><au>Nordt, T</au><au>Pizzulli, L</au><au>F-U, Sack</au><au>Sack, S</au><au>Schumacher, B</au><au>Schymik, G</au><au>Sechtem, U</au><au>Stellbrink, C</au><au>Stumpf, C</au><au>Hoffmeister, H M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Interdisciplinary consensus on indications for transfemoral transcatheter aortic valve implantation (TF-TAVI)</atitle><jtitle>Clinical research in cardiology</jtitle><date>2020-01-01</date><risdate>2020</risdate><volume>109</volume><issue>1</issue><spage>1</spage><epage>12</epage><pages>1-12</pages><issn>1861-0684</issn><eissn>1861-0692</eissn><abstract>Indications for TF-TAVI (transfemoral transcatheter aortic valve implantation) are rapidly changing according to increasing evidence from randomized controlled trials. Present trials document the non-inferiority or even superiority of TF-TAVI in intermediate-risk patients (STS-Score 4–8%) as well as in low-risk patients (STS-Score &lt; 4%). However, risk scores exhibit limitations and, as a single criterion, are unable to establish an appropriate indication of TF-TAVI vs transapical TAVI vs SAVR (surgical aortic valve replacement). The ESC (European Society of Cardiology)/EACTS (European Association for Cardio-Thoracic Surgery) guidelines 2017 and the German DGK (Deutsche Gesellschaft für Kardiologie)/DGTHG (Deutsche Gesellschaft für Thorax-, Herz- und Gefäßchirurgie) commentary 2018 offer a framework for the selection of the best therapeutic method, but the individual decision is left to the discretion of the heart teams. An interdisciplinary TAVI consensus group of interventional cardiologists of the ALKK (Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte e.V.) and cardiac surgeons has developed a detailed consensus on the indications for TF-TAVI to provide an up-to-date, evidence-based, comprehensive decision matrix for daily practice. The matrix of indication criteria includes age, risk scores, contraindications against SAVR (e.g., porcelain aorta), cardiovascular criteria pro TAVI, additional criteria pro TAVI (e.g., frailty, comorbidities, organ dysfunction), contraindications against TAVI (e.g., endocarditis) and cardiovascular criteria pro SAVR (e.g., bicuspid valve anatomy). This interdisciplinary consensus may provide orientation to heart teams for individual TAVI-indication decisions. Future adaptations according to evolving medical evidence are to be expected.Graphic abstractInterdisciplinary consensus on indications for transfemoral transcatheter aortic valve implantation (TF-TAVI).</abstract><cop>Heidelberg</cop><pub>Springer Nature B.V</pub><doi>10.1007/s00392-019-01528-5</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1861-0684
ispartof Clinical research in cardiology, 2020-01, Vol.109 (1), p.1-12
issn 1861-0684
1861-0692
language eng
recordid cdi_proquest_journals_2272481715
source Springer Nature - Complete Springer Journals
subjects Adaptation
Aorta
Aortic valve
Cardiology
Clinical trials
Criteria
Endocarditis
Heart
Implantation
Indication
Interdisciplinary aspects
Medical personnel
Patients
Porcelain
Risk
Surgeons
Surgery
Thoracic surgery
Thorax
title Interdisciplinary consensus on indications for transfemoral transcatheter aortic valve implantation (TF-TAVI)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T01%3A34%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Interdisciplinary%20consensus%20on%20indications%20for%20transfemoral%20transcatheter%20aortic%20valve%20implantation%20(TF-TAVI)&rft.jtitle=Clinical%20research%20in%20cardiology&rft.au=von%20Scheidt%20Wolfgang&rft.date=2020-01-01&rft.volume=109&rft.issue=1&rft.spage=1&rft.epage=12&rft.pages=1-12&rft.issn=1861-0684&rft.eissn=1861-0692&rft_id=info:doi/10.1007/s00392-019-01528-5&rft_dat=%3Cproquest%3E2272481715%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2272481715&rft_id=info:pmid/&rfr_iscdi=true